Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Jan 7;16(1):e0245111. doi: 10.1371/journal.pone.0245111

Performance evaluation of survival regression models in analysing Swedish dental implant complication data with frailty

Adeniyi Francis Fagbamigbe 1,2,3,*, Karolina Karlsson 4, Jan Derks 4, Max Petzold 5
Editor: Feng Chen6
PMCID: PMC7790411  PMID: 33411801

Abstract

The use of inappropriate methods for estimating the effects of covariates in survival data with frailty leads to erroneous conclusions in medical research. This study evaluated the performance of 13 survival regression models in assessing the factors associated with the timing of complications in implant-supported dental restorations in a Swedish cohort. Data were obtained from randomly selected cohort (n = 596) of Swedish patients provided with dental restorations supported in 2003. Patients were evaluated over 9 years of implant loss, peri-implantitis or technical complications. Best Model was identified using goodness, AIC and BIC. The loglikelihood, the AIC and BIC were consistently lower in flexible parametric model with frailty (df = 2) than other models. Adjusted hazard of implant complications was 45% (adjusted Hazard Ratio (aHR) = 1.449; 95% Confidence Interval (CI): 1.153–1.821, p = 0.001) higher among patients with periodontitis. While controlling for other variables, the hazard of implant complications was about 5 times (aHR = 4.641; 95% CI: 2.911–7.401, p<0.001) and 2 times (aHR = 2.338; 95% CI: 1.553–3.519, p<0.001) higher among patients with full- and partial-jaw restorations than those with single crowns. Flexible parametric survival model with frailty are the most suitable for modelling implant complications among the studied patients.

Introduction

Survival regression methods are commonly used to explore heterogeneity among subjects in medical research [1] and to estimate prognostic factors for survival [26]. However, one of the major challenges in survival analysis modelling is clustering among followed subjects, otherwise known as frailty [7,8]. The concept of frailty is an issue of discourse in statistical modelling, including survival analysis. Frailty is a group-specific latent random effect that multiplies into the hazard function. The frailties are unobservable positive quantities. They follow a gamma distribution with a mean of 1 and variance to be estimated from the data. Theoretically, any distribution with positive support (mean = 1) and finite variance may be used to model frailty. In most cases, shared-frailty models are used to model the within-group correlation. Observations within a particular group are often referred to as correlated because they share the same frailty. Let us consider the case of patients attending a dental clinic. Any of the patients may have issues with any of their teeth after a particular intervention. The teeth of a single patient form a cluster. While it is reasonable to assume independence of the dental patients, it is incorrect to assume that the occurrence of infection to any of the teeth within each patient is independent. It is necessary therefore to accommodate the potential “dependency” by assuming that it was the result of a latent patient-level effect or frailty. Non-consideration of clustering in clustered data causes poor model fit and biased estimates. This suggests that a mixed-effects model that contains both the random and fixed effects would be most appropriate to model such outcomes.

The alternative, traditional survival regression models, divided into parametric (Poisson, Weibull), semiparametric (Cox), and nonparametric (Kaplan–Meier) have distinct disadvantages that could make them unsuitable to correctly predict survival outcomes [1,9]. For instance, the Kaplan-Meier model does not accommodate covariates, hence its utilization is limited [1,5]. Although the Cox proportional hazard (CPH) model is the most commonly used model in survival analyses [1,10,11] and has been used extensively in the literature [4,1113], its efficiency is limited for short observation periods [1]. Further, its distribution-free assumption is often violated in long-term studies. In either case, many of the subjects may not have experienced the event of interest and, thus, survival and cumulative hazard functions are incomplete and cannot be extrapolated in the CPH [1]. The CPH models assume a constant hazard, an assumption that is also frequently violated [14,15]. The Cox model has an advantage in that it does not assume the form of the baseline hazard function, therefore, not hindering the prediction of hazards and other related functions for a given set of covariates but this advantage gave birth to its major disadvantage [14]. Moreover, survival and cumulative hazard functions of the CPH model are step functions and, thus, limit the possibility of having smooth functions [10,16].

Parametric models, such as the exponential and Weibull models [1], attempted to overcome some of the shortcomings of the CPH model by producing smooth predictions by assuming a functional form of the hazard [1,17] and directly estimating the absolute and relative effects [14]. The models can be used to estimate the smooth cumulative hazard functions and hazard ratios of risk factors and extrapolate survival and cumulative functions [1]. Nonetheless, the models assume that the survival and hazard functions have a specific distribution which is often too structured and sometimes unrealistic for use with real data [9,10]. In addition, parametric models with complex underlying hazard fail to capture true effects [18,19]. Thus, in most cases, parametric models have insufficient flexibility and, thereby, produce biased cumulative hazard and survival functions [10].

While the disadvantages of non-parametric models can be overcome by the use of stratification, the number of factors used for such stratification may be limited [1]. Another way of alleviating the challenges of the CPH is to use a sufficiently large sample size and extensive study duration [20]. Also, parametric survival models may be useful if available data do not violate the underlying assumptions of the distributions. Despite these mitigations, none of the non-parametric, semi-parametric or parametric models is flexible enough to accommodate structural composition of all real-life data.

Royston and Parmar (RP) therefore developed flexible parametric survival regression (FPSR) models as a result of lack of adequate flexibility of the Cox and parametric survival models [9,10,21]. The FPSR model offers a compromise between the CPH and parametric models and retains the desired features of both types of models. The flexible parametric approach works by relaxing the assumption of linearity of log time by using restricted cubic splines [10,22]. The overall advantages of the FPSR models have been reported in the literature [1,9,14,18,19,23,24]. CPH, parametric and the FPSR models have incorporated frailty options.

Different factors could be associated with complications affecting dental restorations supported by implants but it is not known how non-consideration of the clustering nature of the implants (multiple implants in one subject) affect outcomes of the modelling approach. The need for appropriate statistical models for accurate medical inferences and decisions motivated this study. It is designed to evaluate and compare the application of CPH, parametric and FPSR models to complications affecting dental implants. Implants are clustered within patients and intra-cluster dependency may occur. We hypothesized that models with frailty, and the flexible parametric model with frailty, in particular, would perform better than all other range of models. We aimed to apply different survival analysis regression models to a dataset originating from Sweden [25,26] and assess the performance of the models to identify the model with the best data fit. We considered the (i) Cox proportional hazard models for frailty, (ii) Multilevel mixed-effects parametric survival models for proportional hazard and accelerated failure times and (iii) Flexible parametric survival regression models with frailty generally referred to as the Royston-Parmar (RP) models and their equivalents without frailty.

Methods and statistical models

Cox proportional hazard models with frailty

The Cox proportional hazard (PH) model with frailty is an extension of the Cox PH model developed in 1972 which assumed that hazards are multiplicatively proportional to baseline hazards [5] as shown in Eq (1).

h(t)=h0(t)eβ1x1+β2x2+βkxk (1)

The above equation provides estimates of β1, β2,…,βk, and its variance-covariance matrix but provides no direct estimate of the baseline hazard (h0(t)). However, the model provides an avenue to estimate the baseline cumulative hazard (H0(t)) and baseline survival (S0(t)) which can be used to estimate the h0(t) [10].

Let us assume groups i = 1,……………,n groups with j = 1,……………,ni observations in group i. For the jth observation in the ith group, the hazard is shown in Eq (2).

hij(t)=h0(t)αieβ1x1+β2x2+βkxk (2)

where group-level frailty is estimated by αi. The frailties are unobservable positive quantities and are assumed to have a mean of 1 and a variance θ. Shared-frailty models are used to model within-group correlation; observations within a group are correlated because they share the same frailty. The degree of within-group correlation can be measured by an estimate of “θ”, where θ is 0 in cases where there is no frailty.

By letting vi = log αi, the hazard is as shown in Eq (3)

hij(t)=h0(t)eβ1x1+β2x2+βkxk+νi (3)

which makes the log frailties vi, to be analogous to random effects obtainable in the corresponding standard linear models.

Numerically, let xi be the row vector of covariates for the time interval (t0i; ti) for the ith observation in a dataset with N subjects (i = 1,……….,N). The estimates of the coefficient (βi) of the covariates (Xi) can be estimated by maximizing the partial log-likelihood function in Eq (4)

logL=j=1D[iDjxiβdjlog{kRjexp(xkβ)}] (4)

Where j represents the index of the ordered failure times t(j), j = 1;………; D; such that Dj is the set of dj observations that fail at t(j); dj is the number of failures at t(j); and Rj is the set of observations k that are at risk at time t(j), that is, for all k such that t(0k)<t(j)≤t(k) [2729].

The data for Cox shared-frailty models are usually organized into G groups with the ith group consisting of n1 observations, i = 1,………,G. The estimation of θ is done via maximum profile log-likelihood. For fixed θ, estimates of β and v1,…….,vG are obtained by maximizing the parameters in Eq (5).

logL(θ)=logLCox(β,v1,..vG)+i=1G[1θ{v1ev1}+(1θ+DI){1log(1θ+DI)}logθθ+logΓ(1θ+DI)logΓ(1θ)] (5)

where Di is the number of death events in group i and logLCox(β, v1,………,vG) is the standard Cox partial log-likelihood, with the vi as the vector of the variables’ coefficients indicator which identifies the groups. The jth observation in the ith group has log relative hazard βxij+νi. The values that maximize logL(θ^) are the final estimates of β in νi [30].

Mixed-effects parametric survival models

The mixed-effects parametric survival models otherwise called the multilevel parametric survival models are well known [31]. These models contain both fixed and random effects. The accelerated failure-time (AFT) model and the multiplicative or proportional hazards (PH) model are the most-used models for adjusting survivor functions for the effects of covariates. In the AFT model, log t is expressed as a linear function of the covariates, when random-effects is incorporated, the function yields the function in Eq 6.

logtji=Xjiβ+zjiuj+vji (6)

for j = 1,…………,M, clusters, with cluster j consisting of i = 1,…………,nj observations. The 1 X p row vector Xji contains the covariates for the fixed effects, with regression coefficients (fixed effects) β. The zji has 1 x q dimension and contains the covariates corresponding to the random effects. Also, vji are the observation-level errors with density φ(.). In the PH models, the model contains the covariates which have a multiplicative effect on the hazard function in Eq (7).

h(tji)=h0(tji)exp(Xjiβ+zjiuj) (7)

where h0(t), the baseline hazard function, is assumed to be parametric. Both the exponential and Weibull models can be implemented using the AFT and PH parameterizations, but the gamma and log-logistics and log-normal can only be implemented in AFT and implemented with “mestreg” in Stata.

Flexible parametric survival regression models

The FPSR model is based on a series of models that are modifications of several standard survival models [21] but has additional flexibility [21,23]. These models use restricted cubic splines to model a transformation of the survival function. The Weibull model is one of the most common parametric models and is an approximation of the PH model. It has been criticized for inflexibility in the shape of the baseline hazard function, which either increases or decreases monotonically. Weibull survival function is S(t) = exp(−λtγ), and the corresponding log cumulative hazard scale is ln {H(t)} = ln[−ln{S(t)}] = ln[−ln{exp (−λtγ)}] = ln(λ)+γ ln(t), after transformation. Addition of covariates to the model produces ln {H(t|xi)} = ln(λ)+γ ln(t)+xiβ.

Splines are flexible mathematical functions defined by piecewise polynomials with some constraints to ensure that the overall curve is smooth, are used. The polynomials join one another at points called knots. The fitted function is forced to have continuous 0th, 1st and 2nd derivatives. The most common splines used are cubic splines. Restricted cubic splines with k knots can be fitted by creating k-1 derived variables. For knots k1, k2,…………….kk, and parameters γ0, γ1,…………….γk−1, a restricted cubic spline function can be written as s(x) = γ01z1+⋯…………+γk−1zk−1; where z1 = x = ln(t) and zj(j≥2). The derived variables, zj, are computed as in Eq (8)

zj=(xkj)+3ϕj(xkj)+3(1ϕj)(xkj)+3; (8)

where j = 2,…,k−1; (xkj)+3=max{0,(xa)3};ϕj=(kkkj)/(kkk1);kk is the maximum k, and k1 is the minimum k. The derived variables can be highly correlated and are orthogonalized by using Gram–Schmidt orthogonalization.

The hazard function involves the derivatives of the restricted cubic splines functions as s′(x) = γ1z′12z′2+⋯…………+γk−1z′k−1. The choice of position of knots determines the complexity of the flexible models. Usually, k knots, maximum at 9 knots, has k+1 degrees of freedom (df). The position of the knots (internal) is usually in centiles computed as 100/df. So, for 3 knots, the df is 4 and the knots will be located at centiles 25, 50 and 75. The internal knots are bounded by “boundary knots” which are placed at the minimum and maximum of the distribution of uncensored survival times. The FPSR models become the Weibull model if the number of knots is 0, while γ0 and γ1 are equal to the scale parameter and shape parameter respectively. Royston et al. suggest using 1 or 2 knots for smaller (<10,000) datasets and 4 or 5 for larger (> = 10,000) datasets [10]. The FSPR models are implemented in Stata using “stpm2” with an option for frailty.

In the flexible parametric model, the contribution to the log-likelihood for the ith individual on the log cumulative hazard scale can be written as shown in Eq 9.

lnLi=di(ln[s{ln(ti)|γ,k0}]+ηi)exp(ηi) (9)

where di is the event indicator. The likelihood can be maximized by defining an additional equation for the derivatives of the spline function and constrain the parameters to be equal to the equivalent spline functions in the main linear prediction [22,32].

Model selection criteria

Log-likelihood, Akaike information criteria (AIC) [33] and the Bayesian information criteria (BIC) [34] were used for model selection. Lower values of AIC and BIC indicated a better model fit. AIC and BIC are usually computed and compared separately among different models to determine the best fitting model. However, confusion may arise if the best fitting model according to the AIC is different from that identified by the BIC [14]. Literature suggests that AIC will choose a more complex model irrespective of sample size while BIC is more likely to choose a simpler model [14]. AIC is often preferable in situations when a false negative finding would be considered to be more misleading than a false positive, and BIC is superior in situations where a false positive is as misleading as, or more misleading than, a false negative. AIC is best for prediction as it is asymptotically equivalent to cross-validation. BIC is best for an explanation as it allows consistent estimation of the underlying data generating process [14,35].

The data

The dataset used for this study originates from a project evaluating the effectiveness of dental implant therapy in Sweden. A cohort of 596 randomly selected adults, provided with implant-supported dental restorations in 2003, were followed over 9 years. The extent of dental treatment varied from the replacement of single teeth to the restoration of full jaws. The average number of implants per patient was 4.0 ±2.8 (range 1–12). Complications related to the restorations/implants were scored using the patient as the unit of analysis and timing was recorded in days relative to the time point of implant insertion. The complications included: Loss of a dental implant, development of peri-implantitis and/or occurrence of a technical complication. For details regarding case definitions of the different categories of complications, the reader is referred to Derks et al. [25,26,36]. The occurrence of any of the complications referred to above was considered as an event in the present analyses. There were a total of 1,038 events during the observation period with 469 complications in single-record/single-failure data.

Operational definitions

Median survival time: This is a statistic that refers to how long patients “survive” in general after dental restorative therapy including the use of implants.

The incidence rate is a measure of the frequency with which dental implant complications occurred per day.

IncidenceRate=NumberofnewcasesofdiseaseduringspecifiedperiodTimeeachpersonwasobserved,totalledforallpersons

Ethics approval and patient consent

The research protocol was approved by the regional Ethical Committee, Gothenburg, Sweden (Dnr 290–10), registered at ClinicalTrials.gov (NCT01825772) and study participants signed an informed consent form prior to inclusion.

Results

One of the 596 subjects was excluded from analysis due to missing data. The mean age (in 2003) of the 595 included participants was 62.3 (SD = 9.3) years, with 42% aged 60–69 years, 24% aged 70–79 years and 55% were females. Roughly 60% of patients presented without signs of periodontitis at the 9-year examination, 24% had periodontitis and 16% were edentulous (no teeth). A total of 28% had full-jaw restorations, 48% had partial-jaw restorations and 24% had single crowns, only. Regarding dental products, 31% received Straumann implants (Type A), 20% had Astra Tech implants (Type B), 40% had Nobel Biocare implants (Type C). The remaining 9% of subjects were treated with various other types of implants categorized as Type D.

The overall incidence rate of implant complications was 0.000241 per day. It was higher among those without remaining natural teeth (0.000387) and those who had full-jaw restorations (0.000439). The median survival time (when 50% of implant-carrying subjects would have “failed”) to implant complications was 2476 days, while the 25% survivorship was 820 days. The medium “survival” time was highest among those who had partial-jaw restorations (3347 days), females (3044 days), treated within the public dental service (3044 days), treated with Type A (3347 days) or other dental products (Type D) (3227 days respectively) as shown in Table 1.

Table 1. Distribution of incidence rate and quartile survival times by patients’ characteristics (n = 595).

Characteristics N(%) Days at risk incidence rate Survival time (days)
25% Median (50%) 75%
Age(years) in 2003 mean(sd) 62.3(9.3)
<50 80(13.5) 266436 0.000135 1935 cbc cbc
50–59 121(20.3) 399995 0.000170 1185 cbc cbc
60–69 252(42.4) 813359 0.000299 746 1874 cbc
70–79 145(24.4) 467601 0.000261 593 1927 cbc
Age group
Younger (<60) 201(33.8) 666431 0.000156 1386 cbc cbc
Older (≥60) 394(66.2) 1280960 0.000285 685 1915 cbc
Sex
Male 267(44.9) 872344 0.000288 685 1927 cbc
Female 328(55.1) 1075047 0.000203 899 3378 cbc
Periodontal status
Healthy 356(59.8) 1168495 0.000187 1081 cbc cbc
Periodontitis 144(24.2) 468620 0.000280 868 1966 cbc
No Teeth 95(16.0) 310276 0.000387 471 1185 cbc
Extent of treatment
Full jaw 167(28.1) 537496 0.000439 470 1082 2840
Partial jaw 283(47.6) 928468 0.000208 929 3347 cbc
Single 145(24.4) 481427 0.000083 . cbc cbc
Smoker
Yes 76(12.8) 246840 0.000292 929 2118 cbc
No 519(87.2) 1700551 0.000234 820 2509 cbc
Clinical setting
Public dental service 174(29.2) 575246 0.000214 868 3044 cbc
Private dental service 372(62.5) 1211970 0.000261 807 2210 cbc
Mix 49(8.2) 160175 0.000187 594 cbc cbc
Frequency of maintenance
Regular (annual) 479(82.2) 1565319 0.000259 746 2057 cbc
Irregular (< annual) 104(17.8) 341940 0.000178 1752 cbc cbc
Ever Smoker
Yes 209(35.1) 682082 0.000238 746 2515 cbc
No 386(64.9) 1265309 0.000243 820 2280 cbc
Dental product
Type A 181(31.2) 605090 0.000207 959 3347 cbc
Type B 115(19.8) 374929 0.000272 746 1874 cbc
Type C 230(39.6) 740492 0.000236 929 2604 cbc
Typ D 55(9.5) 180580 0.000222 869 3227
Bone augmentation
No 436(84.7) 1428524 0.000240 820 2476 cbc
Yes 79(15.3) 256548 0.000265 654 2070 cbc
Retention of restoration
Cemented 198(34.1) 664274 0.000117 2057 cbc cbc
Screw-retained 346(59.6) 1122931 0.000314 624 1661 cbc
Both 37(6.3) 119748 0.000275 404 2069 cbc
Total 595 1947391 0.000241 820 2476 cbc

cbc Cannot be computed

Missing data if the sum of categories <595.

The distribution of the incidence rate of implant complications by time is shown in Fig 1. The incidence rate reduced with increasing time of follow-up.

Fig 1. Distribution of incidence rate of dental failure by time.

Fig 1

The hazard and survival functions of dental complications under different distributions

We assessed the hazard function under different models for periodontal status (one of the main prognostic factors) in Fig 2. In Fig 2, the chart in panel (a) is from the Weibull mixed effects parametric proportional hazard (b) Loglogistic mixed effects parametric proportional hazard (c) Cox proportional hazard and (d) Cox smoothed proportional hazard. The hazard for “periodontitis” was consistently higher than the hazard for “healthy” and “no teeth”. The hazard for “healthy” and “no teeth” was similar.

Fig 2. Comparison of the hazard functions of the models using the determinate variable.

Fig 2

In Fig 3, we present the survival function under different models for periodontal status. The chart in panel (a) is from the Weibull mixed effects parametric proportional hazard (b) Loglogistic mixed effects parametric proportional hazard (c) Cox proportional hazard and (d) Cox smoothed proportional hazard for periodontal status. The survival for “periodontitis” was consistently lower than the survival for “healthy” and “no teeth”. The survival for “healthy” and “no teeth” was similar.

Fig 3. Comparison of the survival functions of the models using the determinate variable.

Fig 3

Test of assumption of proportionality

The test of violations of assumptions of the proportional hazard showed that the test was not violated (X2 = 5.50, df = 4, p = 0.240)

Comparison of the survival and hazard functions of the flexible model at different degrees of freedom

We compared the performance of the survival and hazard functions of the flexible model at various degrees of freedom (1, 2, 3 and 6) for the periodontal status of the patients. A degree of freedom of 1 is an equivalent of the Weibull distribution. The hazard functions of the Weibull distribution were different from the hazard functions at the other degrees of freedom. However, the function at 6 degrees of freedom was different and more flexible than at 2 and 3 degrees of freedom (Fig 4A). The survival functions at 2, 3 and 6 degrees of freedom were, however, similar but distinct at 1 degree of freedom (Fig 4B).

Fig 4. Comparison of the survival and hazard functions of the Weibull model and the flexible models.

Fig 4

Selection of the best model

Loglikelihood, AIC BIC for all the models considered, with and without frailty, are presented in Table 2. All three parameters were consistently lower among the flexible frailty models at different degrees of freedom than the Cox PH frailty, parametric frailty models (Table 2). We observed that the AIC and BIC of the parametric models without frailty were consistently lower than those with frailty. Among the FPSR models at different degrees of freedom, the lowest loglikelihood was at df = 6, the lowest AIC was at df = 4, while the lowest BIC was at df = 2. However, for df >1, differences between the lowest and highest loglikelihood, between the lowest and highest AIC and between the lowest and highest BIC were 4.4 (0.45%), 1.47 (0.04%) and 18.7 (0.89%) respectively. According to the AICs, all the FPSR models at df>2 were similar. Hence we chose the simplest of all the FPSR models at df = 2. Our decision was further supported by the significance of the spline variables for the log baseline cumulative hazard (_rcsi) otherwise called the slope of the hazard curve within each of the knots generated by the degrees of freedom. At df = 2, the two slopes were statistically significant: _rcs1 = 2.26 (p<0.001) and _rcs2 = 1.150 (p<0.001). At df = 3, the first two slopes were statistically significant: _rcs1 = 2.25 (p<0.001) and _rcs2 = 1.134 (p<0.001) but the last slope was not significant (_rcs3 = 1.02 (p = 0.107). The slopes at df>2 had similar patterns with the slopes at df = 3.

Table 2. Comparison of the flexible models using different knots.

Frailty Model Model ll(null) ll(model) df AIC BIC
None Cox Cox -2717.70 -2633.63 17 5301.26 5384.09
Parametric Weibull -1187.65 -1134.54 19 2307.07 2399.64
Exponential -1189.12 -1134.86 18 2305.73 2393.43
Log Logistic -1182.18 -1130.25 19 2298.51 2391.08
Gamma -1178.59 -1130.46 20 2300.92 2398.37
Flexible Model df = 1 -1294.47 -1134.54 19 2307.07 2399.64
df = 2 -1294.47 -1128.29 20 2296.58 2394.03
df = 3 -1294.47 -1127.95 21 2297.90 2400.21
df = 4 -1294.47 -1125.68 22 2295.36 2402.55
df = 5 -1294.47 -1124.84 23 2295.69 2407.74
df = 6 -1294.47 -1123.84 24 2295.68 2412.62
Yes Cox Cox with strata -2047.18 -2001.85 17 4037.70 4120.52
Cox frailty -2866.48 -2577.24 17 5188.48 5271.31
Parametric Weibull -4359.71 -3900.89 20 7841.78 7939.22
Exponential -4376.43 -3910.82 19 7859.64 7952.21
Log Logistic -4349.04 -3898.90 20 7837.80 7935.24
Gamma -4363.40 -3905.27 20 7850.54 7947.98
Flexible Model df = 1 -1143.70 -988.24 19 2014.47 2107.04
df = 2 -1143.70 -972.51 20 1985.01 2082.45
df = 3 -1143.70 -971.73 21 1985.45 2087.76
df = 4 -1143.70 -969.99 22 1983.98 2091.17
df = 5 -1143.70 -969.16 23 1984.31 2096.37
df = 6 -1143.70 -968.11 24 1984.22 2101.15

AIC Akaike Information Criteria BIC Bayesian Information Criteria df degrees of freedom ll loglikelihood PH Proportional Hazard AFT Accelerated Failure Rate

Modelling the risk factors of implant complications

We fitted an FPSR model at 2 degrees of freedom to the data and identified the adjusted determinants of implant complications among the patients. Table 3 showed that the adjusted hazard of implant complications was 45% (adjusted Hazard Ratio (aHR) = 1.449; 95% Confidence Interval (CI): 1.153–1.821, p = 0.001) higher among patients with periodontitis than those who were periodontally healthy. While controlling for other variables, the hazard of implant complications was about 5 times (aHR = 4.641; 95% CI: 2.911–7.401, p<0.001) and 2 times (aHR = 2.338; 95% CI: 1.553–3.519, p<0.001) higher among patients with full- and partial-jaw restorations respectively when compared to subjects with single crowns, only. The adjusted hazard of implant complications was 27% (aHR = 1.272; 95% CI: 1.047–1.548, p = 0.016) higher among male patients than females. The adjusted hazard of an implant complication was 40% (aHR = 1.397; 95% CI: 1.069–1.826, p = 0.014) higher among patients provided with Type B dental products with Type A products as reference. Smoking history, type of retention and age were not significant predictors of complications.

Table 3. Adjusted prognostic factors of dental implant complications using FPSR model (df = 2).

Characteristics Adjusted Hazard Ratio 95% CI p-value
Periodontal status
Healthy 1.000
Periodontitis 1.449 1.153–1.821 0.001
No teeth 1.050 0.797–1.383 0.730
Extent of treatment
Full jaw 4.641 2.911–7.401 <0.001
Partial jaw 2.338 1.553–3.519 <0.001
Single 1.000
Age (years) in 2003
<50 1.000
50–59 1.086 0.713–1.652 0.702
60–69 1.108 0.740–1.658 0.620
70–79 0.860 0.559–1.322 0.491
Gender
Male 1.272 1.047–1.548 0.016
Ever smoker
Yes 1.014 0.769–1.337 0.922
Dental product
Type A 1.000
Type B 1.397 1.069–1.826 0.014
Type C 1.074 0.848–1.360 0.554
Type D 1.116 0.779–1.597 0.550
Retention of restoration
Screw-retained 1.000
Cemented 0.870 0.627–1.208 0.406
Both 0.920 0.607–1.395 0.695
_rcs1 2.262 2.080–2.459 <0.001
_rcs2 1.150 1.091–1.213 <0.001

_rcs are the spline variables for the log baseline cumulative hazard

Discussion

This study was designed to apply and compare the performance of semi-parametric, parametric and flexible parametric survival regression models to a dataset on dental implant-related complications with or without frailty. This analytical study showed that models with frailty performed better than those without frailty except among the parametric models where the reverse was the case. This could be ascribed to inconsistencies and inflexibilities of parametric models (Royston and Lambert, 2011). Nonetheless, the AIC and the BIC of the flexible models were lower than those computed from the other models irrespective of whether the clustering nature of the implant data was considered or not.

Therefore, the flexible parametric survival regression model was the best of the three main models considered in this study. Our finding is consistent with findings in earlier studies [10,15,23]. All measures of model fit and model selection adopted in our study were consistently better in the flexible parametric survival regression models than in the other models. Loglikelihood, AIC and BIC were lower in the flexible parametric survival regression models than the Cox PH model and the parametric models. Similar findings have been reported in the literature [15,23,37]. The flexible models had a unique advantage by separating the hazard function into segments (splines) based on the specified degrees of freedom and computing the hazard within each spline [9,10,18,21].

We used AIC and BIC to select the ultimate degrees of freedom to use for the flexible parametric survival regression model. AIC and BIC are measures of the amount of information lost in the models [33,34]. The lower these values, the better the models. In this study, BIC was lowest at 2 degrees of freedom while AIC was lowest at 4 degrees of freedom. This discrepancy has previously been reported [35] and may be due to how the two information measures compute “complexities”. The problem of defining “N” (the number of observations) is not related to AIC because N is not used in computing AIC, which rather uses a constant 2 to weight complexity as measured by k (number of parameters estimated), rather than ln(N) in BIC. According to Stone at al. [38], AIC approximately minimizes the prediction error and is asymptotically equivalent to leave-1-out cross-validation (LOOCV) while BIC is equivalent to leave-k-out cross-validation (LKOCV) [39] and it is not consistent with the amount of data available. However, BIC has the advantage of being consistent. With a very large amount of data, and if the true model is among the candidate models, the probability of selecting the true model based on the BIC criterion would approach 1. This, however, may slightly affect prediction performance. We chose the flexible parametric survival regression model at 2 degrees of freedom as suggested by the BIC because the slopes of the curves within each spline were insignificant after 2 degrees of freedom, the differences in parameter estimates at 2, 3 and 4 degrees of freedom were negligible. Also, the AIC at 2, 3 and 4 degrees of freedom changed by 0.07%, which was considered negligible.

Our finding that the FPSR method with frailty fitted the data used in this study is further corroborated by the behaviour of the hazard and survival functions shown in Figs 24. However, there could be challenges of over-parametrization in the flexible model due to its adaptability and incorporation of up to ten knots. Also, the Cox model makes minimal assumptions about the form of the baseline hazard function and may have hindered the prediction of hazards and other related functions for a given set of covariates. It also results in unsmooth estimated curves and lack of information about what occurs between the observed failure times. Parametric models, on the other hand, produce smooth predictions by assuming a functional form of the hazard. Its assumed form is too structured for use with real data (Royston and Lambert, 2011). Therefore, the non-proportional hazards can be modelled using restricted cubic splines in FPSR models [14] and thereby produce a better fit.

The fitted flexible parametric survival regression model at 2 degrees of freedom showed that the hazard of implant complications was higher among male patients, patients with periodontitis, among patients with either full- or partial-jaw restorations and among patients that were provided with dental product Type B. It is plausible that more extensive restorations are at higher risk for complications through the simple fact that more implants and surfaces are exposed to potential events. More extensive restorations, however, may also serve as a surrogate parameter for the individual’s susceptibility to developing tooth- or implant-related problems. This may be illustrated by the fact that subjects presenting with periodontitis at remaining teeth were at higher risk for implant-related complications. This relationship is most likely explained by the strong association between periodontitis and peri-implantitis [40]. Peri-implantitis was one of the complications recorded in the present study. The background to the other factors identified in the model (sex and dental product) are not understood. It may be speculated that biting force and/or behaviour in terms of oral health may have had an impact.

The covariates included in the flexible model have shown that there is a wide range of factors that contribute to complications affecting dental implants. Their inclusion has influenced the performance of the models as they demonstrated reality. For instance, the risk of implant complications was generally higher among patients with periodontitis than those that were periodontally healthy. No difference, however, was noted between periodontally healthy and edentulous patients. Similar assertions have been made in earlier studies [41,42].

Conclusion

Flexible parametric survival model represents the best approach for estimating the hazard of clustered implant complications including (i) implant loss, (ii) peri-implantitis and (iii) technical complications. The study underscores the need to explore the multilevel (clustering) nature of datasets to be analysed. Non-consideration of the clustering nature of data is potentially misleading. The hazard of complications was higher among male patients, patients with periodontitis, patients with more extensive restorations and was dental product specific.

Acknowledgments

The authors appreciate the logistic supports provided by the Consortium for Advanced Research and Training in Africa (CARTA) to AFF to visit the University of Gothenburg as part of his fellowship at the University of Warwick.

Abbreviations

AFT

Accelerated Failure Time

AIC

Akaike information criteria

aHR

adjusted Hazard Ratio

BIC

Bayesian information criteria

CI

Confidence Interval

CPH

Cox Proportional Hazard

FPSR

Flexible parametric survival regression

IQR

Interquartile range

PH

Proportional hazard

RP

Royston-Palmar

Data Availability

The data underlying the results presented in the study are available from the regional Ethical Committee, Gothenburg, Sweden (Dnr 290-10), ClinicalTrials.gov This study is human research based on sensitive data which cannot be publicly shared. Data contain potentially identifying and sensitive patient information. Interested researchers can contact the Swedish Ethical Review Authority or the Head of Institute, Peter Lingström: Swedish Ethical Review Authority (Etikprövningsmyndigheten) registrator@etikprovning.se Box 2110 750 02 Uppsala, Sweden +46 (0)10-475 08 00 Peter Lingström peter.lingstrom@odontologi.gu.se Professor of Cariology, Institute of Odontology, University of Gothenburg https://www.gu.se/en/odontology/about-us/contactinfo@odontologi.gu.se +46 (0)31-786 2932.

Funding Statement

No specific funding was received. However, the Consortium for Advanced Research and Training in Africa (CARTA) supported AFF to visit the University of Gothenburg as part of his fellowship at the University of Warwick. CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No--B 8606.R02), Sida (Grant No:54100029), and the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The data analysis was carried out during the visit.

References

  • 1.Du X, Li M, Zhu P, Wang J, Hou L, Li J, et al. Comparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world data. PLoS One. 2018;13:1–13. 10.1371/journal.pone.0200807 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Swindell WR. Accelerated failure time models provide a useful statistical framework for aging research. Exp. Gerontol. NIH Public Access; 2009;44:190–200. 10.1016/j.exger.2008.10.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Austin PC. A Tutorial on Multilevel Survival Analysis: Methods, Models and Applications. Int. Stat. Rev. [Internet]. 2017;85:185–203. Available from: 10.1111/insr.12214 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Fagbamigbe AF, Adebowale AS, Morhason-Bello IO. Survival analysis of time to uptake of modern contraceptives among sexually active women of reproductive age in Nigeria. BMJ Open [Internet]. 2015. [cited 2016 Jan 12];5:1–8. Available from: http://bmjopen.bmj.com/cgi/content/long/5/12/e008371 10.1136/bmjopen-2015-008371 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cox D. Regression Models and Life Tables (with Discussion). J. R. Stat. Soc. Ser. B. 1972;34:187–220. [Google Scholar]
  • 6.Fox J. Cox Proportional-Hazards Regression for Survival Data The Cox Proportional-Hazards Model. Most [Internet]. 2002;2008:1–18. Available from: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.110.2264&rep=rep1&type=pdf [Google Scholar]
  • 7.Fagbamigbe AF, Bakre BB. Evaluating Likelihood Estimation Methods in Multilevel Analysis of Clustered Survey Data. African J. Appl. Stat. [Internet]. 2018;5:351–76. Available from: http://www.statpas.org/ajas/admin/articles/pdfs/ajas_2018_01_04_def.pdf [Google Scholar]
  • 8.Fagbamigbe AF, Afolabi RF, Alade KY, Adebowale AS, Yusuf BO. Unobserved Heterogeneity in the Determinants of Under-five Mortality in Nigeria: Frailty Modeling in Survival Analysis. African J. Appl. Stat. [Internet]. 2019;6:565–83. Available from: http://www.statpas.org/ajas/admin/articles/pdfs/ajas_2019_01_04_def.pdf [Google Scholar]
  • 9.Orsini N. Review of Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model by Patrick Royston and Paul C. Lambert. Stata J. 2013. [Google Scholar]
  • 10.Royston P, Lambert PC. Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model. 1st ed Texas: Stata Press; 2011. [Google Scholar]
  • 11.Otwombe KN, Petzold M, Martinson N, Chirwa T. A review of the study designs and statistical methods used in the determination of predictors of all-cause mortality in HIV-infected cohorts: 2002–2011. PLoS One. 2014. 10.1371/journal.pone.0087356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Fagbamigbe AF, Akintayo AO, Oshodi O, Makinde FT, Babalola M, Damilola EA, et al. Survival Analysis and Prognostic Factors of Time to First Domestic Violence after Marriage among Married Women in Africa. Public Health [Internet]. Elsevier Ltd; 2020;181:122–34. Available from: 10.1016/j.puhe.2019.12.003 [DOI] [PubMed] [Google Scholar]
  • 13.Wamala R, Kabagenyi A, Kasasa S. Predictors of time to contraceptive use from resumption of sexual intercourse after birth among women in Uganda. DHS Work. Pap. No. 118 [Internet]. 2015; Available from: http://dhsprogram.com/pubs/pdf/WP118/WP118.pdf
  • 14.Bower H, Crowther MJ, Rutherford MJ, Andersson TML, Clements M, Liu XR, et al. Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study. Commun. Stat. Simul. Comput. [Internet]. Taylor and Francis Inc.; 2019. [cited 2020 Mar 6];1–17. Available from: https://www.tandfonline.com/doi/full/10.1080/03610918.2019.1634201 [Google Scholar]
  • 15.Dickman PW. Comparing Cox and flexible parametric models [Internet]. 2020. [cited 2020 Mar 6]. p. 1–2. Available from: http://pauldickman.com/software/stata/sex-differences-cox/ [Google Scholar]
  • 16.Nelson CP, Lambert PC, Squire IB, Jones DR. Flexible parametric models for relative suvival, with application in coronary heart disease. Stat. Med. 2007. p. 5486–98. 10.1002/sim.3064 [DOI] [PubMed] [Google Scholar]
  • 17.Williams C, Lewsey JD, Mackay DF, Briggs AH. Estimation of Survival Probabilities for Use in Cost-Effectiveness Analyses. Med. Decis. Mak. [Internet]. SAGE Publications Inc.; 2016. [cited 2020 Mar 6];37:0272989X1667061. Available from: http://journals.sagepub.com/doi/10.1177/0272989X16670617 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ng R, Kornas K, Sutradhar R, Wodchis WP, Rosella LC. The current application of the Royston-Parmar model for prognostic modeling in health research: a scoping review. Diagnostic Progn. Res. Springer Nature; 2018;2:1–15. 10.1186/s41512-018-0026-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rutherford MJ, Crowther MJ, Lambert PC. The use of restricted cubic splines to approximate complex hazard functions in the analysis of time-to-event data: a simulation study. J. Stat. Comput. Simul. Taylor and Francis Ltd.; 2015;85:777–93. [Google Scholar]
  • 20.Nijhuis RL, Stijnen T, Peeters A, Witteman JCM, Hofman A, Hunink MGM. Apparent and internal validity of a Monte Carlo-Markov model for cardiovascular disease in a cohort follow-up study. Med. Decis. Making [Internet]. Sage PublicationsSage CA: Thousand Oaks, CA; 2006. [cited 2020 Mar 6];26:134–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16525167 10.1177/0272989X05284103 [DOI] [PubMed] [Google Scholar]
  • 21.Royston P, Parmar MKB. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat. Med. 2002;21:2175–2197. 10.1002/sim.1203 [DOI] [PubMed] [Google Scholar]
  • 22.Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata J. 2009;9:265–290. [Google Scholar]
  • 23.Miladinovic B, Kumar A, Mhaskar R, Kim S, Schonwetter R, Djulbegovic B. A Flexible Alternative to the Cox Proportional Hazards Model for Assessing the Prognostic Accuracy of Hospice Patient Survival. PLoS One. 2012;7:1–8. 10.1371/journal.pone.0047804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kearns B, Stevenson MD, Triantafyllopoulos K, Manca A. Generalized Linear Models for Flexible Parametric Modeling of the Hazard Function. Med. Decis. Mak. 2019;39:867–78. 10.1177/0272989X19873661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Karlsson K, Derks J, Håkansson J, Wennström JL, Molin Thorén M, Petzold M, et al. Technical complications following implant-supported restorative therapy performed in Sweden. Clin. Oral Implants Res. [Internet]. Blackwell Munksgaard; 2018. [cited 2020 Mar 26];29:603–11. Available from: http://doi.wiley.com/10.1111/clr.13271 [DOI] [PubMed] [Google Scholar]
  • 26.Derks J, Schaller D, Håkansson J, Wennström JL, Tomasi C, Berglundh T. Effectiveness of Implant Therapy Analyzed in a Swedish Population: Prevalence of Peri-implantitis. J. Dent. Res. [Internet]. SAGE Publications Inc.; 2016. [cited 2020 Mar 26];95:43–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26701919 10.1177/0022034515608832 [DOI] [PubMed] [Google Scholar]
  • 27.Vittinghoff E, Glidden D V., Shiboski SC, McCulloch CE. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models [Internet]. Second Edi Washington DC: Springer; 2012. [cited 2020 Aug 17]. Available from: https://www.stata.com/bookstore/regression-methods-biostatistics/ [Google Scholar]
  • 28.Xu Y, Cheung YB. Frailty models and frailty-mixture models for recurrent event times. Stata J. DPC Nederland; 2015;15:135–54. [Google Scholar]
  • 29.Xu Y, Cheung YB. Frailty models and frailty-mixture models for recurrent event times: Update. Stata J. DPC Nederland; 2018;18:477–84. [Google Scholar]
  • 30.Therneau Grambsch. Modeling Survival Data: Extending the Cox Model. New delhi, India: Springer; 2000. [Google Scholar]
  • 31.Crowther MJ. Multilevel mixed-effects parametric survival analysis: Estimation, simulation, and application. Stata J. Promot. Commun. Stat. Stata [Internet]. SAGE Publications Inc.; 2019. [cited 2020 Aug 17];19:931–49. Available from: http://journals.sagepub.com/doi/10.1177/1536867X19893639 [Google Scholar]
  • 32.Andersson TML, Lambert PC. Fitting and modeling cure in population-based cancer studies within the framework of flexible parametric survival models. Stata J. DPC Nederland; 2012;12:623–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Akaike H. Information theory as an extension of the maximum likelihood principle In: Petrov BN, Csaki F, editors. Second Int. Symp. Inf. Theory. Ed. Budapest: Akademiai Kiado; 1973. p. 267–281. [Google Scholar]
  • 34.Schwarz G. Estimating the Dimension of a Model. Ann. Stat. Institute of Mathematical Statistics; 1978;6:461–4. [Google Scholar]
  • 35.STATA. AIC and BIC. Stata J. 2020;21:1–9. [Google Scholar]
  • 36.Derks J, Håkansson J, Wennström JL, Tomasi C, Larsson M, Berglundh T. Effectiveness of implant therapy analyzed in a Swedish population: Early and late implant loss. J. Dent. Res. [Internet]. SAGE Publications Inc.; 2015. [cited 2020 Mar 26];94:44S–51S. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25503901 10.1177/0022034514563077 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Brewer MJ, Butler A, Cooksley SL. The relative performance of AIC, AICC and BIC in the presence of unobserved heterogeneity. Freckleton R, editor. Methods Ecol. Evol. [Internet]. British Ecological Society; 2016 [cited 2020 Mar 9];7:679–92. Available from: http://doi.wiley.com/10.1111/2041-210X.12541 [Google Scholar]
  • 38.Stone M. An asymptotic equivalence of choice of model by cross-validation and Akaike’s criterion. J. R. Stat. Soc. Ser. B. 1977;39:44–7. [Google Scholar]
  • 39.Shao J. An asymptotic theory for linear model selection. Stat. Sin. 1997;7:221–42. [Google Scholar]
  • 40.Schwarz F, Derks J, Monje A, Wang HL. Peri-implantitis. J. Clin. Periodontol. Blackwell Munksgaard; 2018;45:S246–66. [DOI] [PubMed] [Google Scholar]
  • 41.Culshaw S. Periodontal Disease: Its Impact on Restorative Dentistry. Prim. Dent. J. 2017;6:25–31. 10.1177/205016841700600103 [DOI] [PubMed] [Google Scholar]
  • 42.Wittneben JG, Buser D, Salvi GE. Complication and failure rates with implant-supported fixed dental prostheses and single crowns: a 10-year retrospective study. Clin Implant Dent Relat Res. 2014;16:356–364. 10.1111/cid.12066 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Feng Chen

27 Nov 2020

PONE-D-20-32590

Performance Evaluation of survival regression models in analysing Swedish dental implant complication data with frailty

PLOS ONE

Dear Dr. Fagbamigbe,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 11 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Feng Chen

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please correct your reference of  "p=0.000" to "p<0.001" or as similarly appropriate, as p values cannot equal zero.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

5. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 3 in your text; if accepted, production will need this reference to link the reader to the Table.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This paper evaluated the performance of 13 survival regression models in analyzing dental implant complication based on a case study in Sweden. The topic is interesting and worth of investigation. The results indicate that the flexible parametric survival model with frailty outperforms the other alternatives. The findings provide a good suggestion on method selection for modeling dental implant complication. Overall, the paper is generally well organized and qualified to be published in PLOS ONE.

Reviewer #2: This paper evaluated the performance of 13 survival regression models in assessing the factors associated with the timing of complications in implant-supported dental restorations in a Swedish cohort. The topic is interesting. The methods sound. The results are meaningful and useful. One only issue is that the resolution of some figures could be increased.

Reviewer #3: This paper is written in a way that takes the reader through the models very well.

I have some minor comments:

I am not familiar with dental data, so I didn't have a good idea about what an event was, and what a complication was in the sentence of: line 223: "There were a total of 1,038 events during the observation period with 469 complications in single-record/single-failure data".

line 225-230: Is the model improvement assessed in line with how complicated the model is? As in, typically in multivariate models a new term is only included if the improvement in model fit is significant, as a particular level of significance. Was this considered here? It may be worth stating that the degree of improvement is not relevant in selecting a best fitting model. Reading the results section it does seem like there was a consideration for how complicated the model was.

line 285: is it relevant to have the p-value to 4 decimal places? Wouldn't 2 do?

Table 3: are the estimates too precise? Would 2 decimal places for the hazard ratio and confidence intervals still provide the same relevant information, and p-values to 2 significant figures? (or 1 if p<0.01)

Also, present p=0.000 as p<0.001.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jan 7;16(1):e0245111. doi: 10.1371/journal.pone.0245111.r002

Author response to Decision Letter 0


8 Dec 2020

November 28th 2020

Dear Editor

PLOS ONE

Through

Feng Chen

Academic Editor

PONE-D-20-32590

Performance Evaluation of survival regression models in analysing Swedish dental implant complication data with frailty

We the authors of above mentioned paper appreciate the efforts and comments of the editor and the eminent reviewers. We have addressed all these comments. A point-by-point response to the issues in our revised manuscript is listed below.

Please note that we used the file with the tracked changes to describe where the changes were made.

Editorial Comments

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Thank you. We have reformatted the manuscript in line with Plos one requirements

2. Please correct your reference of "p=0.000" to "p<0.001" or as similarly appropriate, as p values cannot equal zero.

Thank you we have changed all its appearance

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

This is human research based on sensitive data which cannot be publicly shared. Data contain potentially identifying and sensitive patient information. The interested party is referred to the regional Ethical Committee, Gothenburg, Sweden (PO Box 401, 405 30 Gothenburg, Sweden) and/or the University of Gothenburg, Gothenburg, Sweden (PO Box 100, 405 30 Gothenburg, Sweden).

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Kindly see the comment above.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Thank you. It has been moved

5. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 3 in your text; if accepted, production will need this reference to link the reader to the Table.

Thank you. It has been moved

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Thank you all.

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Thank you all.

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

Thank you all.

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Thank you all.

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This paper evaluated the performance of 13 survival regression models in analyzing dental implant complication based on a case study in Sweden. The topic is interesting and worth of investigation. The results indicate that the flexible parametric survival model with frailty outperforms the other alternatives. The findings provide a good suggestion on method selection for modeling dental implant complication. Overall, the paper is generally well organized and qualified to be published in PLOS ONE.

Thank you all.

Reviewer #2: This paper evaluated the performance of 13 survival regression models in assessing the factors associated with the timing of complications in implant-supported dental restorations in a Swedish cohort. The topic is interesting. The methods sound. The results are meaningful and useful. One only issue is that the resolution of some figures could be increased.

Reviewer #3: This paper is written in a way that takes the reader through the models very well.

Thank you all.

I have some minor comments:

I am not familiar with dental data, so I didn't have a good idea about what an event was, and what a complication was in the sentence of: line 223: "There were a total of 1,038 events during the observation period with 469 complications in single-record/single-failure data".

The complications considered in the present analysis included (i) loss of an implant, (ii) development of peri-implantitis and (iii) technical problems (lines 220-222). The occurrence of any of these were considered as an “event”. We added a sentence to the relevant paragraph (lines 223-224) for clarification.

line 225-230: Is the model improvement assessed in line with how complicated the model is? As in, typically in multivariate models a new term is only included if the improvement in model fit is significant, as a particular level of significance. Was this considered here? It may be worth stating that the degree of improvement is not relevant in selecting a best fitting model. Reading the results section it does seem like there was a consideration for how complicated the model was.

Thank you. We didn’t set for model complication. We set out to select the best model irrespective of its simplicity or complexity in as much it considered frailty.

line 285: is it relevant to have the p-value to 4 decimal places? Wouldn't 2 do?

Thank you, three decimal places are usually recommended by most journals including Plos One.

Table 3: are the estimates too precise? Would 2 decimal places for the hazard ratio and confidence intervals still provide the same relevant information, and p-values to 2 significant figures? (or 1 if p<0.01)

Thank you, yes, they will provide same information. Again, the journals requirement is 3 decimal places.

Also, present p=0.000 as p<0.001.

Thank you we have changed all its appearance

________________________________________

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Thank you all.

Adeniyi Fagbamigbe

On behalf of authors

Attachment

Submitted filename: Response to reviewers comment MP KK JD.docx

Decision Letter 1

Feng Chen

23 Dec 2020

Performance Evaluation of survival regression models in analysing Swedish dental implant complication data with frailty

PONE-D-20-32590R1

Dear Dr. Fagbamigbe,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Feng Chen

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Acceptance letter

Feng Chen

28 Dec 2020

PONE-D-20-32590R1

Performance Evaluation of survival regression models in analysing Swedish dental implant complication data with frailty

Dear Dr. Fagbamigbe:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Feng Chen

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewers comment MP KK JD.docx

    Data Availability Statement

    The data underlying the results presented in the study are available from the regional Ethical Committee, Gothenburg, Sweden (Dnr 290-10), ClinicalTrials.gov This study is human research based on sensitive data which cannot be publicly shared. Data contain potentially identifying and sensitive patient information. Interested researchers can contact the Swedish Ethical Review Authority or the Head of Institute, Peter Lingström: Swedish Ethical Review Authority (Etikprövningsmyndigheten) registrator@etikprovning.se Box 2110 750 02 Uppsala, Sweden +46 (0)10-475 08 00 Peter Lingström peter.lingstrom@odontologi.gu.se Professor of Cariology, Institute of Odontology, University of Gothenburg https://www.gu.se/en/odontology/about-us/contactinfo@odontologi.gu.se +46 (0)31-786 2932.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES